NCT03862131 2025-07-29PROACTWashington University School of MedicinePhase 2 Terminated49 enrolled 12 charts
NCT00577798 2023-11-03Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving DoxorubicinUniversity of NebraskaCompleted10 enrolled 3 charts
NCT01719562 2023-05-19MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity AddendumWake Forest University Health SciencesPhase NA Completed28 enrolled 17 charts
NCT00436566 2022-08-05Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By SurgeryMayo ClinicPhase 2 Completed122 enrolled 22 charts
NCT01009918 2021-03-30Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving TrastuzumabUniversity of South FloridaPhase 2 Completed468 enrolled 16 charts
NCT02006979 2019-10-25Acute Exercise Cardioprotection From DoxorubicinUniversity of British ColumbiaPhase 1 Completed27 enrolled 18 charts